glp 1 europe GLP-1 Agonist Market Oral GLP-1 Market to Rise
Description
Pfizer has said it expects pills to eventually capture about a third of the obesity drug market, which is predicted to grow to about $130 billion by the end of the decade.
GLP-1 receptor (GLP-1R) agonists applied peripherally or centrally decrease food intake and increase glucose-stimulated insulin ...
From adherence and payer solutions to supply chain and Build vs
Optimal nutrient absorption
Long-term GLP-1 strategies, microdosing GLP-1 for maintenance to keep the weight off for good.
